Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

S Lonardi, A Sobrero, G. Rosati, M Di Bartolomeo, M Ronzoni, G. Aprile, B Massida, Mario Scartozzi, M Banzi, M G Zampino, F. Pasini, P Marchetti, M. Cantore, A Zaniboni, L Rimassa, L Ciuffreda, D. Ferrari, S. Barni, V Zagonel, E MaielloE Rulli, R. Labianca, TOSCA (Three or Six Colon Adjuvant) Investigators

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
JournalAnnals of Oncology
DOIs
Publication statusE-pub ahead of print - Feb 23 2017

Keywords

  • Journal Article

Cite this